Lumosity to pay $2 million to settle deceptive advertising charges
By
Lois A. Bowers
Jan 07, 2016
Lumosity has agreed to pay $2 million to settle Federal Trade Commission charges that it deceived consumers with unfounded claims that its “brain games” can reduce or delay cognitive impairment...
‘Historic’ $100 million Alzheimer’s bill passes in House, heads to president’s desk
By
Lois A. Bowers
Dec 20, 2018
A bipartisan bill that authorizes $100 million in funding over five years to create a new public health infrastructure to combat Alzheimer’s disease is headed to the president’s desk after being passed...
Antipsychotic prescribing increases in assisted living during pandemic: study
By
Kimberly Bonvissuto
Apr 11, 2022
The prescribing of antipsychotic medications in assisted living communities and nursing homes has increased by 1.5% since the beginning of the COVID-19 pandemic, according to a recent study.
Higher habitual coffee intake may slow cognitive decline
Nov 30, 2021
Higher baseline coffee consumption also was linked to slower Aβ-amyloid accumulation during a 126-month study period, as shown on brain MRI scans.
Fund Alzheimer’s research, Senate committee told
By
Lois A. Bowers
Apr 06, 2016
Witnesses testifying before the Senate Special Committee on Aging, and committee members themselves, called for more funding for Alzheimer’s research at an April 6 hearing.
McKnight’s Senior Living Online Expo set for June 13
By
Lois A. Bowers
May 14, 2018
Registration is now open for the second annual McKnight’s Senior Living Online Expo, where attendees can earn up to three continuing education credits and interact with several companies serving...
Residents abandoned during wildfire, claims lawsuit against assisted living community
By
Lois A. Bowers
Nov 22, 2017
Four former residents of a California assisted living community sued the community’s developer and management companies on Monday, maintaining that they were abandoned during an October wildfire...
Long-term care tops list of retirement concerns of American workers: study
By
Kimberly Bonvissuto
Dec 01, 2021
Paying for long-term care, declining health that requires long-term care, and outliving savings and investments are among the top retirement concerns of American workers, according to the results of a...
Medicare will only cover Aduhelm for patients in clinical trials
Apr 08, 2022
The decision is meant to protect patients while gathering more clinical data on whether the medication actually helps slow declines in thinking.
3 FDA advisory panel members resign in wake of controversial approval of new Alzheimer’s drug
By
Kimberly Bonvissuto
Jun 11, 2021
Three members of a Food & Drug Administration advisory panel resigned this week over the agency’s controversial decision on Monday to approve a novel therapy for Alzheimer’s disease.